Dietary supplementation with nicotinamide, a vitamin B-derived coenzyme present in most living cells, might delay or even prevent neurodegeneration in glaucoma.
“Following the positive results of animal laboratory studies, we are moving toward human clinical trials,” Jeffrey M. Liebmann, MD, director of the glaucoma service at Columbia University Medical Center, told Ocular Surgery News.
Protecting retinal ganglion cells (RGCs) and their axons is an important therapeutic goal in glaucoma, hard to achieve and measure but worth pursuing.
“We have plenty of options now to lower
Uncategorized